跳至主要内容
临床试验/NCT02680054
NCT02680054终止4 期

Investigation of Appropriate Timing of Additional Insulin Dosing for Fat and Protein in Children With Type 1 Diabetes Using Multiple Daily Injections

Oxford University Hospitals NHS Trust2 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2016年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
38
试验地点
2
主要终点
Time of Peak Glucose Level Following Test Meal

研究概览

简要总结

The aims of the study are to see if additional insulin doses for the fat and protein in a meal, given at different times, improve blood glucose levels and are safe and acceptable to children with Type 1 diabetes using multiple daily insulin injections.

详细描述

The study design is a repeated measures study involving the provision of a standard high protein/high fat evening test meal on 3 different evenings within a 7-day period in the same study subject. The children/adolescents will be instructed to give an insulin dose for the carbohydrate before the meal (calculated using their optimal insulin to carbohydrate (ICR) - 20%). In addition they will have an additional dose for the fat and protein content either before (together with the dose for the carbohydrate in the meal [control meal]), 1 hour after, or 2 hours after the meal. These will be carried out in a random order in each subject. Continuous glucose monitoring (CGM) will be carried out for the whole 7 day period. Questionnaires will assess the acceptability to young people and their parents of the extra insulin doses.

After an initial contact in the clinic, and provision of patient information leaflets, the research nurse or dietitian will telephone the patient and family after a week to answer any questions they may have about the study. If they are keen to participate, an appointment will be arranged for consent and to commence the study (Visit 1).

At Visit 1 the investigators will obtain informed consent and commence a week-long run-in period for participants to optimise insulin to carbohydrate ratio at the evening meal. During this week subjects will be requested to test capillary blood glucose (BG) levels at 7 points throughout the day (pre-meals, 2 hrs after meals and bed). They will be asked to eat a fat and protein free meal on one of these days. If necessary, adjustments to the insulin to carbohydrate ratio (ICR) or long-acting insulin doses will be made over the telephone by an experienced member of their clinical team. This is to decrease the likelihood of a correction bolus for a high BG level being required at the evening meal during the study week.

At the end of the run-in week, participants will then attend the outpatient clinic or day care ward research facility at the Oxford Children's Hospital or the Horton Hospital outpatient clinic in Banbury or the Royal Berkshire Hospital in Reading (Visit 2). At this visit, the subcutaneous glucose sensor will be inserted by the research nurse and children and young people and their families will be trained on its use prior to the study commencing. CGM records glucose levels every 5 minutes over 7 days and thus provides much more information than routine capillary BG testing. It also alarms to alert patients of high and low glucose levels. Children and young people will also record their BG levels from routine finger pricks, pre-prandially and before bed and on waking in the morning.

Also at Visit 2, the study dietitian will review BG readings and food diary from the previous week and optimise ICR doses of rapid acting insulin. This ratio will then be used to calculate insulin doses for the study meals. On three evenings over the next 7 days, the children will eat a standard high protein/high fat meal. The evenings will not be set, but will depend on the child and family schedule. The child and family will be able to choose which days during the study period on which they complete the study meals but will be advised to avoid days when the participant has undertaken lots of exercise, has had frequent hypoglycaemic episodes or has been unwell.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
6 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of Type 1 diabetes (for at least a year)
  • On multiple daily insulin injections, including basal long-acting insulin and rapid-acting insulin before each meal.
  • HbA1c < 75 mmol/mol (9.0%)
  • Participant and/or parent/legal guardian willing and able to give informed consent for participation in the study.
  • Family have a freezer in which to safely store the test meals.
  • In the Investigator's opinion, is able and willing to comply with all trial requirements.

排除标准

  • HbA1c greater than 75 mmol/mol (9.0%)
  • Child unwilling to agree to second insulin injection at a meal-time
  • Untreated coeliac disease or other concomitant condition likely to affect BG control
  • Food allergies (other than controlled Coeliac Disease)
  • Vegetarians, vegans or patients with religious dietary restrictions (as the standard meal contains meat)
  • Participant taking any glucose-containing medication concurrently

研究组 & 干预措施

Arm 1 (usual treatment)

Active Comparator

Insulin dose (insulin Aspart, NovoRapid) for the fat and protein in a high-fat, high-protein meal is given at the same time as the insulin for the carbohydrate content BEFORE the meal. The dose is calculated on an individual basis according to the usual insulin to carbohydrate ratio for that child.

干预措施: Insulin, Asp(B28)- (Drug)

Arm 2

Active Comparator

Insulin dose (insulin Aspart, NovoRapid) for the fat and protein in a high-fat, high-protein meal is given one hour after the meal. The dose is calculated on an individual basis according to the usual insulin to carbohydrate ratio for that child.

干预措施: Insulin, Asp(B28)- (Drug)

Arm 3

Active Comparator

Insulin dose (insulin Aspart, NovoRapid) for the fat and protein in a high-fat, high-protein meal is given two hours after the meal. The dose is calculated on an individual basis according to the usual insulin to carbohydrate ratio for that child.

干预措施: Insulin, Asp(B28)- (Drug)

结局指标

主要结局

Time of Peak Glucose Level Following Test Meal

时间窗: assessed up to 12 hours following the test meal

Glucose measured on the continuous subcutaneous glucose monitor

Peak Glucose Level Following Test Meal

时间窗: assessed up to 12 hours following the test meal

Glucose measured on the continuous subcutaneous glucose monitor

Peak Glucose Excursion From Baseline Following Test Meal

时间窗: assessed up to 12 hours following the test meal

Glucose measured on the continuous subcutaneous glucose monitor

次要结局

  • Number of Participants With Hypoglycaemia Events Following the Insulin Dosing(assessed up to 12 hours following the test meal)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rachel Besser

Consultant in Paediatric Diabetes

Oxford University Hospitals NHS Trust

研究点 (2)

Loading locations...

相似试验